| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 49,781 | 56,996 | 50,430 | 72,855 | | Cost of Revenue | 29,732 | 29,310 | 28,170 | 31,619 | | | Gross Profit | 20,049 | 27,686 | 22,260 | 41,236 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 29,634 | 26,141 | 28,894 | 32,848 | | Non Recurring |
-
| 5,500 | 7,100 | 9,349 | | Others | 2,095 | 2,148 | 1,751 | 3,551 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (11,680) | (6,103) | (15,485) | (4,512) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 993 | (993) | (2,269) | | Earnings Before Interest And Taxes | (11,771) | (5,893) | (16,478) | (6,295) | | Interest Expense | (89) | 81 | 8 |
-
| | Income Before Tax | (11,682) | (5,974) | (16,486) | (6,295) | | Income Tax Expense | 432 | 400 | 358 | 1,717 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,897) | (6,374) | (16,844) | (8,012) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,114) | (6,374) | (16,844) | (8,012) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,114) | ($6,374) | ($16,844) | ($8,012) |
|
1.52% Nasdaq 
Income Statement
